Standing Advisory Committee Meeting August 8, 2019 Agenda 2 p.m. - - PowerPoint PPT Presentation

standing advisory
SMART_READER_LITE
LIVE PREVIEW

Standing Advisory Committee Meeting August 8, 2019 Agenda 2 p.m. - - PowerPoint PPT Presentation

Standing Advisory Committee Meeting August 8, 2019 Agenda 2 p.m. 2:05 p.m. Welcome & MHBE Executive Update 2:05 p.m. 2:30 p.m. Affordability Work Group Report 2:30 p.m. 2:45 p.m. Out-of-Pocket Cost Calculator Initiative 2:45


slide-1
SLIDE 1

Standing Advisory Committee Meeting

August 8, 2019

slide-2
SLIDE 2

Agenda

2 p.m.–2:05 p.m. Welcome & MHBE Executive Update 2:05 p.m.–2:30 p.m. Affordability Work Group Report 2:30 p.m.–2:45 p.m. Out-of-Pocket Cost Calculator Initiative 2:45 p.m.–3:00 p.m. Prescription Drug Search 3:00 p.m.–3:35 p.m. Draft 2021 Plan Certification Standards: Concepts and Discussion 3:35 p.m.–3:45 p.m. SHOP Update & Engagement 3:45 p.m.–3:55 p.m. State Reinsurance Program 3:55 p.m.–4 p.m. Public Comments

2

slide-3
SLIDE 3

Executive Update

slide-4
SLIDE 4

Affordability Work Group Report

slide-5
SLIDE 5

Figure 1. Factors of health coverage that affect market participation and health systems interaction.

5

slide-6
SLIDE 6

Chart 1. Uninsured, non-elderly Maryland adults stratified by income category (by FPL) and age group.

6

49,000 31,800 19,500 12,700 16,400 10,500 8,500 4,800 28,600 5,200 5,100 3,400 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 100,000 19-34 35-44 45-54 55-64

Age Category

139-300 301-400 400+

SOURCE: Presentation to the Affordability Work Group. (Families USA 2019)

slide-7
SLIDE 7

Chart 2. The prevalence of chronic disease in the individual market by age groups.

7

SOURCE: Prevalence of chronic disease across age groups. (MHBE 2019)

slide-8
SLIDE 8

Table 3: Intervention Population #1: Young Adults (18-34)

8

Sub-Group Near Term Long Term

General Women Young Adults with Substance Use Disorder/Behavioral Health needs 1. Marketing investment focused on Young Adults 2. Value Plans:

  • a. Evaluate the outcomes of the Value Plans
  • b. Marketing investment in Value Plans

3. Consumer Decision Support Tools:

  • a. Development of an Out-of-Pocket Cost Calculator
  • b. Development of a plan shopping experience
  • ptimized to display service categories customized

by the user, or automatically, by age 4. Development of a health literacy program focused on Young Adults 5. Successful implementation of the Maryland Easy Enrollment Health Insurance Program Continued marketing investment focused on Young Adults 139% - 400 % FPL Eligible for financial assistance 1. A marketing investment focused on Young Adults 2. The State should commission a study on a supplemental premium subsidy for Young Adults that does not modify the existing federal tax credit structure. The study should:

  • a. Analyze potential interaction with the State

Reinsurance Program, and federal pass through, for the following scenarios:

  • i. Supplemental premium subsidy w/ an

independent funding source

  • ii. Supplemental premium subsidy w/ funding

carved-out from the existing premium assessment under Md. INSURANCE Code

  • Ann. § 6-102.

1. Establishment of a state-based supplemental premium subsidy for Young Adults:

  • a. Utilizing only state funds or,
  • b. Utilizing state & federal pass-

through funds under a 1332 waiver.

slide-9
SLIDE 9

Table 3: Intervention Population #1: Young Adults (18-34)

9

Sub-Group Near Term Long Term 139% - 400 % FPL Eligible for financial assistance

  • i. Supplemental premium subsidy under i

& ii seeking federal pass through under a 1332 waiver

  • a. Estimate required funding amount & identify

potential funding sources

  • b. Project impact of the subsidy on the

individual market for a five- and ten-year time horizon

  • c. Be updated at a later time to account for the

implementation of other policies, i.e. the Maryland Easy Enrollment Health Insurance Program 1. Establishment of a state-based supplemental premium subsidy for Young Adults:

  • a. Utilizing only state funds or,
  • b. Utilizing state & federal pass-

through funds under a 1332 waiver. 400+% FPL Ineligible for financial assistance 1. Continuation of the State Reinsurance Program 1. Continuation of the State Reinsurance Program 2. Establishment of a state-based supplemental premium subsidy for Young Adults:

  • a. Utilizing only state funds or,
  • b. Utilizing state & federal pass-

through funds under a 1332 waiver.

slide-10
SLIDE 10

Table 4. Intervention Population #2: Individuals with Chronic Diseases

10

Sub-Group Near Term Long Term

General 1. Value Plans

  • a. Evaluate the outcomes of the Value Plans
  • b. Study separate medical & drug deductibles and/or

generic drugs before deductible

  • i. Requirement within Actuarial Value ranges (+2/-

4)

  • ii. Impact on the utilization and cost-sharing of
  • ther benefit categories

2. Chronic Disease Management Programs

  • a. Increase participation in these programs through

education/health literacy

  • b. Analysis of State Reinsurance Program claims for

conditions that are drivers of claims to the SRP and the prevalence of those conditions c. Promotion of those with diabetes, hypertension, and depression into Care Management Programs

  • d. State-wide coordination of chronic disease

management programs and measurements across markets & programs (Medicare & Medicaid) including diabetes prevention programs 3. Consumer Decision Support Tools

  • a. Plan shopping experience that is responsive to

consumer’s unique service category needs

  • b. Prescription Drug Search that relays cost sharing,

limitations/ exclusions, prior authorizations, and consumer protections for formulary changes 1. Continuation of the State Reinsurance Program

slide-11
SLIDE 11

Table 4. Intervention Population #2: Individuals with Chronic Diseases

11

Sub-Group Near Term Long Term

General 4. Provider Networks

  • a. Expansion of care coordination for those with chronic

diseases

  • b. Expand capacity through telemedicine services

c. Improve health literacy for the newly insured with provider selection 1. Continuation of the State Reinsurance Program

slide-12
SLIDE 12

Opportunity for comment

  • The Affordability Work Group Report is available for public comment until August 30, 2019.
  • Link to report: https://www.marylandhbe.com/wp-content/uploads/2019/08/Affordability-Work-

Group-Report.pdf

  • Please submit any comments to MHBE.publiccomments@maryland.gov.

12

slide-13
SLIDE 13

Out of Pocket Cost Calculator Initiative

slide-14
SLIDE 14

What is an Out of Pocket Cost Calculator

  • Out of pocket costs include deductibles, coinsurance, and copayments for covered services,

plus all costs for services that are not covered

  • Consumer support decision tools such as out of pocket cost calculators (OOPCC) can assist

with comparing plans based on estimated total healthcare costs for a year including premiums, medications, copays, coinsurance and other costs not paid by health insurance

  • The tool is intended to only be an estimate of general costs, and not a full decision support

tool such as in-person assistance

14

slide-15
SLIDE 15

History

  • Out-of-pocket Calculator implemented in 2014 HIX
  • Noted by issuers and stakeholders as yielding incorrect results
  • Created by Connecture as a part of the HIX Plan Management “CAP” Module
  • Out-of-pocket Calculator not included in the HBX
  • The 2019 Affordability Work Group included a robust Out-of-Pocket Cost Calculator as an

important consumer decision support tool to ensure informed enrollment into coverage.

  • Individuals w/ Chronic Diseases
  • Young Adults

15

slide-16
SLIDE 16

Actions Taken Towards Implementation

  • State-Based Marketplace discussion facilitated by National Academy for State Health Policy
  • Discussion with Colorado Health to determine data utilized and formulary
  • All-payer claims data received from Center for Improving Value in Health Care (CIVHC)
  • Doctor/outpatient/hospital costs are calculated based on an average for each age group,

health usage level, and zip code

  • Yearly cost estimate= (Monthly premium-Estimated APTC) + (Out of pocket costs)
  • Out of pocket costs =covered medications, doctors visits, outpatient visits, hospital

procedures

  • Discussion with CMS on effectiveness of implementation
  • Discussion with Maryland Health Care Commission to obtain claims data

16

slide-17
SLIDE 17

SBM OOPCC – Discussion

17

Goals  Lower the number of clicks to find the best place  Ensure that consumers evaluate plans on factors other than premium  Simplify the plan selection process Approaches Connecticut

  • Asks consumer 5 questions – categorizes consumers into 4 different levels of utilization (high,

medium, low, and no costs) California

  • With questions consumer is sorted into high, medium, and low usage.
  • Consumers can sort based off calculated OOPCs

Minnesota

  • Consumer questions determine expected utilization and services

Display Differences California

  • Research found that consumers enjoy seeing a dollar amount

DC

  • Research was inconclusive

Connecticut

  • Uses dollar sign due to the tool being based off actuarial models, reflective of the variability of

utilization Utilization Connecticut

  • Originally OOPCC was external to plan shopping: 18,000 – 20,000 users
  • After integration: 50,000 users (110,000 total enrollees)
  • Noted usage by broker community

DC

  • OOPCC tool in front of the application
  • 32,000 users (30% of population)
  • 92% of users go through the tool
slide-18
SLIDE 18

SBM OOPCC – Prescription Drug Tool

  • All states found that Prescription Drug search was a value-add to their consumer decision

support toolkit

  • Note: importance for enrollees with chronic conditions, i.e. utilization of multiple

prescription drugs

  • Note: ensure timeliness of data with quarterly carrier data submissions
  • States are mixed with the inclusion of the Prescription Drug Search results in determination
  • f OOPC

18

slide-19
SLIDE 19

SBM OOPCC – Adverse Experiences & Advice

  • Data validation and auditing (specifically for prescription drugs) are critical for OOPCC accuracy
  • DC: Prescription Drug Search tool was out-of-date for mid-year formulary changes
  • Important to consider important sub-populations
  • CT: Native American users
  • Intuitive design and ease-of-use are critical to tool utilization given difference in health literacy
  • Important to provide consumers with access to additional information about the OOPCC development
  • WA: Giving people more explanation allowed users to trust the tool more

19

slide-20
SLIDE 20

CMS – Discussion on Effectiveness of Implementation

  • Approximately 10% of shoppers use this feature in anonymous browsing
  • Calculation of total yearly cost is a mandated feature of plan shopping, so consumer must

utilize feature when applying for coverage

  • If necessary inputs are not provided, the system will default to specific values
  • Value of tool is hard to estimate
  • No current data to support change in shopping behavior

20

slide-21
SLIDE 21

MHCC – Data Sharing Discussion

  • Points of clarification on APCD data
  • Kaiser Permanente’s staffing model and professional claims
  • Data lag and adjustments that would need to be made for changes in inflation, trend, etc.
  • Linking Pharmacy and Behavioral Health Coverage
  • Defining Utilization Bands

21

slide-22
SLIDE 22

MHBE – Approach & Next Steps

  • Given access to Maryland’s All-Payer Claims Database (APCD) development of a proprietary tool and

cost estimation algorithm was supported by internal stakeholders

  • MHBE Policy will inform stakeholders (SAC & General) on the OOPCC initiative and will seek comment

until August 30, 2019:

  • 1. General comments on important factors to consider in tool development.
  • 2. Specific comments on whether outputs should be symbolic or prescriptive of the OOPC magnitude.
  • MHBE Policy is engaging with the Maryland Health Care Commission and Hilltop (consulting with

technical expertise) to develop an algorithm for the OOPCC utilizing the data fields in the (APCD)

  • MHBE received the algorithm from Colorado, Hilltop has provide their insights
  • Prescription Drug Search Tool is in the requirement phase

22

slide-23
SLIDE 23

Prescription Drug Search

slide-24
SLIDE 24

Rationale

  • Knowing whether a plan covers a prescribed drug, what copayments or coinsurance the

consumer must pay, and what alternative drugs may be covered, can make a difference in plan shopping

  • DC Health Benefit Exchange Prescription Drug Search Tool
  • Requires carriers to update their Prescription Drug Templates in SERFF throughout the year

when making any of the following changes to information provided in the Prescription Drug

  • Templates. Changes include:
  • Removal of covered drugs
  • Addition of covered drugs
  • Placement of a covered drug into a higher cost-sharing tier
  • Additional of any new requirements for prior authorization, step therapy or other limitations
  • Intent was to streamline the process by which these updates flow from the carrier database to

the DC Health Link database

slide-25
SLIDE 25

Functionality

  • Consumers will be able to search for drug formularies during QHP shopping or viewing QHP

plans in anonymous browsing

  • Drugs can be search by name or searched by drugs associated with an illness
  • Can select up to five drugs from search results
  • After the household is enrolled in a QHP plan, they will be able to search for drug coverage of

their enrolled plan in their Account Dashboard in the consumer portal

  • Information displayed will include:
  • Drug name
  • Drug form
  • Dosage
  • Drug tier description
  • Copay amount for each plan

25

slide-26
SLIDE 26

Search Page

26

slide-27
SLIDE 27

Results Page

27

slide-28
SLIDE 28

2021 Plan Certification Standards & Policy Concepts

slide-29
SLIDE 29

29 SOURCE: “The Most Important Health Insurance Chart You’ll Ever See,” The Motley Fool, Keith Spreights, 09/05/17

slide-30
SLIDE 30

2020 Plan Certification Standards

  • MHBE developed 2020 Plan Certification Standards in support of agency policy priorities:

1. Lower premiums and reduce consumer exposure to health care costs:

  • Implementation of “Value” Plans at the bronze, silver, and gold metal levels.
  • Establishment of the 2019 Affordability Work Group to develop recommendations to strengthen

the individual market

  • Establishment of the State Benchmark Plan Work Group to develop recommendations on

potential modifications to the State Benchmark Plan

2. Increase consumer choice

  • MHBE did not promulgate standards

3. Expand access to care

  • Implementation of an Essential Community Provider Petition Process

30

slide-31
SLIDE 31
  • Value Plans reduce consumer out-of-pocket costs and increase access to before deductible

services:

  • Increased consumer choice of QHP options in 2020 (+3 from 2019)

2020 Qualified Health Plan Landscape

31

slide-32
SLIDE 32

2021 Plan Certification Standards & Policy Concepts

  • 2021 Plan Certification Standards & Policy Concepts seek to:

1. Build off improvements in 2020. 2. Establish reasonable consumer expectations for out-of-pocket costs. 3. Align consumer incentives for health care service utilization. 4. Increase enrollee effectuation rates in the individual marketplace. 5. Align carrier incentives to manage members with high costs. 6. Increase access to stand-alone dental coverage through Maryland Health Connection.

32

slide-33
SLIDE 33

Value Plan Concepts

slide-34
SLIDE 34

2015 – 2016 Prevalence of Select Conditions.

34 16.30% 11.40% 5.20% 15.60% 11.90% 4.70% 14.00% 9.00% 5.00% 14.00% 9.00% 4.00% 0.00% 2.00% 4.00% 6.00% 8.00% 10.00% 12.00% 14.00% 16.00% 18.00% Hypertension Diabetes Depression On-Exchange 2015 On-Exchange 2016 All Markets 2015 All Markets 2016

SOURCE: Spending and Use Among Maryland’s Privately Insured (MHCC 2018 & 2019)

slide-35
SLIDE 35

2016 – 2017 Drivers of Spending Growth in the Individual Market.

35

SOURCE: Spending and Use Among Maryland’s Privately Insured (MHCC 2019)

slide-36
SLIDE 36

2015-2017 Prescription Drug PMPM by Drug Type, Individual Market.

36

SOURCE: Spending and Use Among Maryland’s Privately Insured (MHCC 2019)

slide-37
SLIDE 37

2015-2017 Prescription Drug Utilization by Drug Type, Individual Market.

37

SOURCE: Spending and Use Among Maryland’s Privately Insured (MHCC 2019)

slide-38
SLIDE 38

2015-2017 Prescription Drug Costs by Drug Type, Individual Market.

38

SOURCE: Spending and Use Among Maryland’s Privately Insured (MHCC 2019)

slide-39
SLIDE 39

Expansion of Preventive Services for Certain Chronic Disease (HDHP Parity Rule)

  • BACKGROUND: IRS Notice 2019-45 expanded the scope of preventive services to be

covered before deductible by a high-deductible health plan to include certain services for certain chronic diseases.

39

slide-40
SLIDE 40

Expansion of Preventive Services for Certain Chronic Disease (HDHP Parity Rule)

  • CONCEPT: Apply the expanded list of preventive services for chronic diseases in IRS Notice

2019-45 to non-HDHP qualified health plans in the individual market.

  • GOAL: To improve health outcomes, increase utilization of high value care, lower out-of-

pocket costs for enrollees with chronic diseases, and align individual market plans with state- wide population health initiatives.

  • PROPOSAL OPTIONS:

1. BROAD: Apply the HDHP Parity Rule to all non-HDHP QHPs. 2. NARROW: Apply the HDHP Parity Rule to all Value Plans.

  • CONSIDERATIONS:

1. Impact to premiums and actuarial value

40

slide-41
SLIDE 41

Out-of-Pocket Cost and Deductible Stability Plan

  • CONCEPT: Leverage the “Value” Plans structure to incrementally implement Value-Based

Insurance Design concepts and promote medical adherence.

  • GOAL: Provide consumers with reasonable expectations of deductibles and out-of-pocket

costs while promoting cost-sharing structures that: 1. Increase the use of high-value care. 2. Decrease the use of low-value care. 3. Limit premium increases attributable to increased actuarial value.

  • EXTERNALITIES:

1. Increase market participation with the availability of high value plans. 2. Align products in the individual market with state-wide initiatives under the Total Cost of Care Waiver. 3. Create incentives for value-based product innovation

41

slide-42
SLIDE 42

Out-of-Pocket Cost and Deductible Stability Plan

YEAR 2020: Implement “Value” plans with deductible and before deductible service requirements.

42

Requirements Bronze Silver Gold Minimum offering Issuer must offer at least 1 “Value” plan. Issuer must offer at least 1 “Value” plan. Issuer must offer at least 1 “Value” plan. Branding Required for 2020. Optional. Optional. Deductible ceiling No requirement. Lower deductibles are encouraged. $2500 or less. $1000 or less. Services Before Deductible Issuer may allocate no less than three office visits across the following settings:  Primary Care Visit (not including preventive care)  Urgent Care Visit  Specialist Visit  Primary Care Visit  Urgent Care Visit  Specialist Care Visit  Laboratory Tests  X-rays and Diagnostics  Imaging  Generic Drugs*  Primary Care Visit  Urgent Care Visit  Specialist Care Visit  Laboratory Tests  X-rays and Diagnostics  Imaging  Generic Drugs

*Encouraged.

slide-43
SLIDE 43

Out-of-Pocket Cost and Deductible Stability Plan

YEAR 2021: No changes for the Value Bronze Plan. Limited modifications to the Value Silver and Value Gold Plans.

  • Both Value Silver and Value Gold Plans: No change in deductible ceiling, lower deductibles

encouraged.

  • Value Silver only:
  • Requirement #1 – Modify before deductible services to include Generic Drugs.
  • Requirement #2 – Maintain (or decrease) cost sharing for Primary Care Visit and Urgent Care Visit.
  • Requirement #3 – Modify before deductible services to exclude Imaging.
  • Flexibility – To help issuers meet Value Silver requirements offsets to increases in AV may include:

1. Increased cost sharing for Specialist Care Visit, Laboratory Services, and X-rays and Diagnostics. 2. Limitations for Laboratory Services and X-rays and Diagnostics. 3. Exclusion of X-Rays and Diagnostics or Laboratory Services from Before Deductible Services (not recommended).

43

slide-44
SLIDE 44

Out-of-Pocket Cost and Deductible Stability Plan

YEAR 2021: No changes for the Value Bronze Plan. Limited modifications to the Value Silver and Value Gold Plans.

  • Value Gold only:
  • Requirement #1 – Maintain (or decrease) cost sharing for Primary Care Visit, Urgent Care Visit, and

Generic Drugs.

  • Flexibility – To help issuers meet Value Gold requirements offsets to increases in AV may include:

1. Increased cost sharing for Specialist Care Visit, Laboratory Services, X-rays and Diagnostics, and Imaging. 2. Limitations for Laboratory Services, X-rays and Diagnostics, and Imaging. 3. Exclusion of Imaging from Before Deductible Services.

  • Modification to Value Gold prescription drug structure to reduce out-of-pocket costs:

1. Implement a prescription drug deductible ceiling of no greater than $250. 2. Include Preferred Brand Drugs as a Before Deductible Service.

44

slide-45
SLIDE 45

Out-of-Pocket Cost and Deductible Stability Plan

  • YEAR 2021: No changes for the Value Bronze Plans. Limited modifications to the Value

Silver and Value Gold Plans. Note: Value Gold does not include modified prescription drug structure.

45

Requirements Bronze Silver Gold Minimum offering Issuer must offer at least 1 “Value” plan. Issuer must offer at least 1 “Value” plan. Issuer must offer at least 1 “Value” plan. Branding Required. Required. Required. Deductible ceiling No requirement. Lower deductibles are encouraged. $2500 or less. $1000 or less. Services Before Deductible Issuer may allocate no less than three office visits across the following settings:  Primary Care Visit  Urgent Care Visit  Specialist Visit  Primary Care Visit  Urgent Care Visit  Specialist Care Visit  Laboratory Tests*+  X-rays and Diagnostics*+  Generic Drugs  Primary Care Visit  Urgent Care Visit  Generic Drugs  Specialist Care Visit  Laboratory Tests*  X-rays and Diagnostics*  Imaging*+

GREEN = Maintain, or decrease, cost sharing from 2020. *May be subject to limitation.

+May be excluded from before deductible services.

slide-46
SLIDE 46

Out-of-Pocket Cost and Deductible Stability Plan

YEAR 2022: Deductible Increment Rule Base Year and no change to before deductible services.

  • Deductible Increment Rule Base Year:
  • 1. A formula to determine yearly allowable increases to the deductible ceilings for Value Silver and

Value Gold Plans. For the 2022 Base Year:

  • Value Silver Deductible Ceiling = 6%(2022 Maryland Median Wage)
  • Value Gold Deductible Ceiling = 2.5%(2022 Maryland Median Wage)
  • For both, the final deductible ceiling is the output rounded upward to the nearest 100th.

46

slide-47
SLIDE 47

Out-of-Pocket Cost and Deductible Stability Plan

YEAR 2023: Implement Deductible Increment Rule.

  • Deductible Increment is the amount the deductible ceilings may increase for Value Gold

and Value Silver plans from the base year.

  • OPTION 1: The deductible ceiling is adjusted every two years.
  • OPTION 2: The deductible ceiling is adjusted every year.
  • Deductible Increment factor may be draw from other indicators of medical cost growth, for

example:

  • 1. Increases in the Annual Out-of-Pocket Maximum.
  • 2. Deductible thresholds established by the IRS for High Deductible Health Plans.
  • 3. A Maryland-specific index.

47

slide-48
SLIDE 48

Plan Certification Concepts

slide-49
SLIDE 49

PayNow URL Requirement

  • CONCEPT: Require issuers participating on Maryland Health Connection to implement a

PayNow URL, i.e. to allow consumers to pay their first month’s premium at the point of enrollment.

  • GOAL: Increase coverage effectuation in the individual market.

1. Promote market stability through increased member months. 2. Lowers the administrative barriers to access coverage for consumers.

  • EXTERNALITIES:

1. When coupled with other enrollment initiatives (the Maryland Easy Enrollment Health Insurance Program) this requirement may increase coverage up-take for target populations. 2. Creates a uniform customer service experience on Maryland Health Connection.

  • UTILIZATION: The PayNow URL was utilized 11,000+ in Open Enrollment 2018.

49

slide-50
SLIDE 50

Co-pay Accumulator Program Transparency

  • CONCEPT: Require issuers to disclose in their “Important Information About This Plan”

document if they utilize a Co-pay Accumulator Program for prescription drugs covered in their formulary and provide information on how the program may impact their out-of-pocket costs.

  • GOAL: Increase coverage transparency for enrollees with who utilize coupons to reduce the

cost their prescription drug. 1. Increase informed decision making.

50

slide-51
SLIDE 51

Expand Access to Stand-Alone Dental Coverage

  • CONCEPT: Implement special enrollment periods for Stand-Alone Dental Coverage offered
  • n Maryland Health Connection for the following trigger events:

1. Determination of eligibility for Medical Assistance Programs. 2. Determination of eligibility for a Qualified Health Plan. 3. New enrollment in the Small Business Health Options Program. 4. Access to an excepted benefits HRA.

  • GOAL: Expand access to dental coverage and increase enrollment in Stand-Alone Dental

Plans offered on Maryland Health Connection.

51

slide-52
SLIDE 52

Increased Premium Rating Options for Small Employers

  • CONCEPT: Require SHOP issuers offer at least one QHP at the bronze, silver, and gold

metal levels that allows for Composite Rating.

  • GOAL: Expand access to alternative premium options for small employers participating on

the SHOP.

52

slide-53
SLIDE 53

Lower Administrative Barriers for New Market Entrants

  • CONCEPT: Offer optional sample plan designs at the bronze, silver, and gold metal levels.
  • GOAL: Lower administrative barriers for potential new market entrants with limited

experience with plan design development.

53

slide-54
SLIDE 54

Regulatory Concepts: Individual Market

slide-55
SLIDE 55

Accumulator Transfer

  • CONCEPT: Require issuers to transfer contributions to the deductible and out-of-pocket

maximum to remaining enrolled members of a QHP policy in instances where the termination

  • f the subscribing enrollee is involuntary, for specific termination reasons:

1. Enrollment in Medicare; 2. Enrollment in group coverage; 3. An enrollee is determined ineligible for QHP coverage due to an unresolved citizenship/immigration status inconsistency under 45 CFR 155.315; or 4. Death.

  • GOAL: Reduce out-of-pocket costs for remaining household members that have maintained

enrollment who would otherwise have to restart contributions under a new QHP policy.

  • Draft regulatory language will be released with the Concept Paper.

55

slide-56
SLIDE 56

Claims and Utilization Management Incentive Payments

  • BACKGROUND: In Maryland’s State Innovation Waiver to Establish a State Reinsurance,

MHBE indicated that it would explore options to add incentive structures to the SRP to promote claims and utilization management for high cost enrollees.

  • CONCEPT: Allocate a portion of SRP surplus (no more than 2% of SRP for the applicable

assessment year) for incentive payments for issues that demonstrate year-over-year lower claims cost growth in proportion to risk: 1. Claims costs and risk scores would be compared year-to-year. 2. After adjusting for enrollee risk and enrollment in cost-sharing reduction plans, plans that demonstrate that their claims cost growth has decreased as compared to the previous year, would be eligible to receive incentive payments. 3. The maximum amount a carrier can receive in payments is 75% of the amount estimated savings identified in the Carrier State Reinsurance Program Accountability Report.

56

slide-57
SLIDE 57

Claims and Utilization Management Incentive Payments

  • GOAL: Orient incentives structures in the State Reinsurance Program to promote increased

claims and utilization management for high claim/high risk members.

  • EXTERNALITY:

1. Opportunity to generate additional pass-through to support incentive payments.

  • Draft regulatory language will be released with the Concept Paper.

57

slide-58
SLIDE 58

State Innovation Waiver Concepts

slide-59
SLIDE 59

Increase Access to Catastrophic Plans

  • CONCEPT: Receive a State Innovation Waiver to allow for those older than 30 old to enroll in Catastrophic

Plans in the individual market.

  • GOAL: Expand access to additional product offerings to increase participation in the individual market.
  • OPTIONS:

1. NARROW: Open eligibility to Catastrophic Plans for those older than 30. 2. BROAD: NARROW + The establishment of a Health Expenditure Account (HEA) to be utilized to pay for medical services. HEA would be partially funded with pass-through that would have been allocated to APTC for enrollees that shift from Metal Level into Catastrophic Plans.

  • EXTERNALITIES:

1. Catastrophic Risk Pool Implications. 2. Consideration of concurrent implementation of other strategies, i.e. Young Adult Subsidy for metal level plans, that could impact risk pool. 3. Consideration of SRP impact on Catastrophic Plan rates during the waiver.

59

slide-60
SLIDE 60

Opportunity for comment

  • The 2021 Plan Certification Standards & Policy Concepts are available for public comment

until August 30, 2019.

  • Please submit any comments to MHBE.publiccomments@maryland.gov.

60

slide-61
SLIDE 61

State Reinsurance Program

slide-62
SLIDE 62

State Reinsurance Program Update

  • MHBE has contracted the actuarial firm, Lewis & Ellis, to perform

analysis on several key areas related to the SRP

  • They are currently working to provide the following:
  • True cost of the 2019 reinsurance program
  • Recalculate the dampening factor for 2020
  • An updated 10-year projection
  • Update the estimated 2020 attachment point

62

slide-63
SLIDE 63

State Reinsurance Program Update

  • 2020 State Reinsurance Program Parameters Document should

be completed by the end of August, and will include:

  • Updated estimated parameters
  • Risk adjustment dampening factor
  • 10 year projection
  • Actual cost for 2019
  • Reinsurance attestation (to support EDGE server utilization)
  • Carrier accountability report requirements

63

slide-64
SLIDE 64

SHOP Update and Engagement

slide-65
SLIDE 65

Strategic Initiatives to Grow SHOP Participation

  • Development of a web-based SHOP Marketplace
  • Similar to individual marketplace web-site
  • 1332 Waiver application to change how the SHOP tax credit

subsidy is administered

  • Outreach to legislators, Chambers of Commerce, and trade

associations to increase awareness of the SHOP

  • Presented to Senator Hester’s Small Business Workgroup
  • Investment in marketing the SHOP to small businesses

65

slide-66
SLIDE 66

SHOP Advisory Committee (SHAC)

  • First meeting was held in July
  • Members include brokers, carriers, small business owners, and

local chambers of commerce

  • Initial meeting provided background on the SHOP, an initial

discussion of platform development, and goals of the SHAC

  • Will be forming a Requirements Subcommittee
  • Future meetings are tentatively set for:
  • August 30th, September 13th and 27th
  • One of these will likely be a webinar based on group

availability

66

slide-67
SLIDE 67

Public Comment